Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|February 23, 2018
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
British Journal of Haematology|January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Hematological Oncology|July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategySimonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Lancet (London, England)|December 15, 2010
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 studyMichele Cavo, Paola Tacchetti, Francesca Patriarca, et al.
Blood|June 19, 2013
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated resultsFrancesca Gay, Valeria Magarotto, Claudia Crippa, et al.
British Journal of Haematology|July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 studyVincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
European Journal of Haematology|November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian expertsFrancesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Pageof 26